Repurposing generic drugs: Experts envision new regulatory pathway
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)GDUFAGenericsProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)